(MENAFN- The Peninsula) Reuters
JOHANNESBURG - International agencies and charitable foundations providing COVID-19 vaccines for Africa should order African-made vaccines, South African President Cyril Ramaphosa told a global COVID-19 summit on Thursday.
Ramaphosa's comments came after South African pharmaceutical company Aspen said it could slash its capacity to produce a COVID vaccine manufactured with drug substance from Johnson & Johnson after getting no orders.
After struggling early in the pandemic to secure COVID vaccines as rich countries hoarded available doses, many African countries are now well-supplied with shots but have struggled to get them into arms. The challenges include hesitancy and logistics.
Read Also
- Messi tops Forbes' highest-paid athletes list
- Spain, Morocco to open land borders next week after 2 years
- Dehydrated birds falling from sky in India amid record heatwave
Ramaphosa told the summit co-hosted by the United States that African manufacturers must be supported to ensure developing capabilities on the continent were retained.
'International agencies that have had a lot of money donated to (them) for purchasing and procuring vaccines for developing economy countries are not buying vaccines from African vaccine manufacturers. Even for those vaccines that are destined for African countries,' Ramaphosa said. 'This immediately just devalues the whole process of local manufacturing.'
'A number of African countries are now stepping up to produce vaccines for the 1.3 billion Africans, ... vaccines produced in Africa must be procured in Africa for Africa's people.'
Separately on Thursday, a senior World Health Organization (WHO) official told a briefing that lessons would be learnt from Aspen's difficulties.
Dr Abdou Salam Gueye, WHO Africa's director of emergency preparedness and response, said the Aspen project had shown that good COVID-19 vaccines could be produced in South Africa.
He said the lack of orders was because global vaccine distribution scheme COVAX, the main buyer of vaccines for Africa, had enough supplies.
John Nkengasong, director of the Africa Centres for Disease Control and Prevention, said global health security would be undermined if companies like Aspen were not backed.
'We have all lived through this challenge of inequity in vaccines, access and distribution, we don't want to live through that again,' he said.
MENAFN12052022000063011010ID1104204614
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.